QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,169 signal articles · 358 in last 24h · 110,743 total before filter · latest 49m ago
358last 24h
2381last 7d
429● bullish (7d)
221● bearish (7d)
202publishers
AllMacro258Earnings1449M&A100Regulatory17Product17Analyst22
✕ clear all filtersticker: EDSAsentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment
Insider Monkey113d agoneutral
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment

Edesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical study of EB06, which is a treatment for moderate-to-severe nonsegmental vitiligo, is […]